AGL 38.09 Increased By ▲ 0.15 (0.4%)
AIRLINK 195.00 Increased By ▲ 1.09 (0.56%)
BOP 9.35 Increased By ▲ 0.03 (0.32%)
CNERGY 5.82 Decreased By ▼ -0.02 (-0.34%)
DCL 8.46 Decreased By ▼ -0.22 (-2.53%)
DFML 35.35 Decreased By ▼ -1.11 (-3.04%)
DGKC 95.20 Increased By ▲ 2.66 (2.87%)
FCCL 35.30 Increased By ▲ 1.33 (3.92%)
FFBL 85.66 Increased By ▲ 3.36 (4.08%)
FFL 12.77 Increased By ▲ 0.02 (0.16%)
HUBC 124.99 Increased By ▲ 4.38 (3.63%)
HUMNL 13.50 Decreased By ▼ -0.10 (-0.74%)
KEL 5.22 No Change ▼ 0.00 (0%)
KOSM 6.95 Increased By ▲ 0.43 (6.6%)
MLCF 44.20 Increased By ▲ 2.09 (4.96%)
NBP 59.89 Increased By ▲ 0.08 (0.13%)
OGDC 213.01 Increased By ▲ 1.84 (0.87%)
PAEL 37.95 Increased By ▲ 0.37 (0.98%)
PIBTL 8.08 Increased By ▲ 0.01 (0.12%)
PPL 190.90 Increased By ▲ 0.58 (0.3%)
PRL 38.82 Increased By ▲ 0.65 (1.7%)
PTC 25.50 Increased By ▲ 2.05 (8.74%)
SEARL 100.00 Increased By ▲ 2.06 (2.1%)
TELE 8.06 Decreased By ▼ -0.16 (-1.95%)
TOMCL 34.50 Decreased By ▼ -0.53 (-1.51%)
TPLP 13.20 Decreased By ▼ -0.35 (-2.58%)
TREET 22.06 Decreased By ▼ -0.67 (-2.95%)
TRG 54.42 Increased By ▲ 1.55 (2.93%)
UNITY 33.20 Increased By ▲ 0.24 (0.73%)
WTL 1.54 Increased By ▲ 0.02 (1.32%)
BR100 11,538 Increased By 154.1 (1.35%)
BR30 35,739 Increased By 527.2 (1.5%)
KSE100 107,844 Increased By 1568.6 (1.48%)
KSE30 33,929 Increased By 576 (1.73%)

Medical experts on Saturday highlighted the lack of public awareness about Chronic Obstructive Pulmonary Disease (COPD), which has a prevalence rate of 2.1 percent in Pakistan's population aged 40 years and above. COPD is a chronic lung (or respiratory) condition affecting both urban and rural population in Pakistan.
Discussing the impact and correlation between COP and cigarette smoking, healthcare professionals said that smoking was among the most common causes of COPD, which kills as many as 3 million people worldwide every year. Highlighting the rapid increase in the prevalence rate of COPD, they feared that the respiratory disease might become the fourth-leading cause of death in the world and the third-leading cause of death in middle-income countries by 2030. They, however, said that COPD could also be caused by air pollution and exposure to biomass fuels.
In many areas in Pakistan, they said, air pollution is a problem and in some rural districts where cooking indoors with biomass fuels is widespread. Dr Ali Sarwar Zuberi, Pulmonologist, Medicine Department at Aga Khan University, who handles COPD patients explained: "The main risk factors for COPD are tobacco smoke, (including second-hand smoke), and exposure to biomass fuels and other indoor and outdoor air pollutants," he said.
Recently, a large epidemiological study called BREATHE was conducted in 10 countries of the Middle East, North Africa and Pakistan in the first international collaborative attempt to document the prevalence and burden of COPD in this region of the world. The findings of the study are derived from interviews of over 60,000 respondents in the general population. This study is first of its kind to evaluate the impact of COPD and cigarette smoking in this part of the world.
A number of important findings emerge from the BREATHE Study which may promote awareness of COPD and potentially make a significant impact on the management of COPD in this region in the coming years. The BREATHE Study demonstrated that the prevalence rate in Pakistan is as high as 2.1 percent in the population aged 40 years and above. The overall prevalence in the 11 countries is 3.6 percent.
The report also mentioned that smoking "is a major and growing public health issue in the country". According to the study, cigarette smoking rate in Pakistan is 15.1 percent. A gender-wise break-up of data showed that 30 percent men and 2 percent women were found involved in some form of smoking. Dr Ali told this correspondent that most patients were still not receiving a diagnosis because general practitioners did not have access to spirometry equipment or were not adequately trained. "There are a number of different treatments available depending on the severity or stage of COPD and it is important that new treatments are made available to those who need them," he maintained.

Copyright Business Recorder, 2013

Comments

Comments are closed.